20Med Therapeutics is a Dutch biotechnology company applying innovative nanotechnology for the development of RNA therapeutics. Our non-viral delivery platform is based on bioresponsive polymers specifically designed for the efficient intracellular delivery of oligonucleotides. 20Med Nanoparticles are widely applicable for the delivery of oligonucleotide based therapeutics using various routes of administration.

Categorieën